Boots launches No7 for men
STAMFORD, Conn. U.K. beauty retailer Boots has announced the launch of its No7 skin care line for men.
The No7 for Men includes 11 products including face washes, shave recovery balm and a men’s version of its Protect & Perfect Anti-Aging Serum. The products launched on Boots.com before going on shelf in Boots high street stores.
According to Boots’ research, nine out of 10 men think cosmetics and clothes give them more pulling power, and 7 out of 10 admit to using concealer.
The company added that men’s skin is twice as oily as women’s, something that increases with age. However, their skin can lose up to 60 percent more moisture than women. The perils of the razor blade and constant shaving can mean men lose elasticity from their skin. As a result, the line helps to protect the skin from water loss.
Freeman Beauty introduces two Feeling Beautiful products
NEW YORK Freeman Beauty has announced the release of a new of skin care products for face and body.
For facial care, there’s the new Feeling Beautiful Pear Refining Facial Cleanser. The product has Salicylic Acid to help ban blemishes for clear skin. For the body, there is the new Feeling Beautiful Avocado & Oatmeal Purifying Clay Body Wash.
The products will join Freeman’s portfolio of bath and body products, which includes Blackberry 2-in-1 Exfoliating Body Wash, Mandarin Moisturizing Body Wash, Guava Salt Body Scrub, Pomegranate Sugar Body Scrub, White Grape Toning Body Lotion and Olive Shea Body Butter.
CVS stocks Wild Child’s Quit Nits
NEW YORK Wild Child, an Australian-based natural health care products company, began selling in January its Quit Nits head lice products at CVS pharmacies.
Initially, the products are being stocked in the first aid section of the stores and will then be moved to the hair care aisle after the first phase of sales, according to the company.
The Quit Nits product line includes both a treatment cream and a preventative spray made with natural ingredients originating in the Australian outback for those consumers searching for a homeopathic and natural approach to head lice removal.
With a U.S. pharmacy distribution deal, Wild Child hopes to gain a 20 percent share of the $100 million OTC head lice treatment market within its first 12 months of operation. In addition, within the next two years the company will attempt to raise $40 million to $50 million through an initial public offering on the Australian Securities Exchange.